The frequency, hematological characteristics, and end-of induction residual disease in B-acute lymphoblastic leukemia with BCR-ABL1-like chimeric gene fusions in a high-risk cohort from India

Leuk Lymphoma. 2022 Oct;63(10):2474-2478. doi: 10.1080/10428194.2021.1929964. Epub 2021 May 24.

Affiliations

¹ Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Pediatric Hematology/Oncology Unit, Department of Pediatric Medicine, Advanced Pediatric Center, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
³ Adult Clinical Hematology Unit, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 34027795
DOI: 10.1080/10428194.2021.1929964

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cohort Studies
Fusion Proteins, bcr-abl / genetics
Gene Fusion
Humans
India / epidemiology
Neoplasm, Residual / genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / epidemiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics

Substances

Fusion Proteins, bcr-abl